Search
Sutilain
go.drugbank.com/drugs/DB09379ApprovedWithdrawn[T169] Sutilain was developed by Abbott and FDA approved on June 12, 1969. It is currently discontinued.[L2368]
Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
go.drugbank.com/drugs/DB10284ApprovedInvestigationalNeisseria meningitidis serogroup B recombinant lp2086 a05 protein variant antigen is a sterile vaccine for intramuscular injection indicated for the active immunization to prevent invasive disease caused by
NOV-002
go.drugbank.com/drugs/DB05393InvestigationalNOV-002 is approved and marketed in the Russian Fereration by Pharma BAM under the trade name Glutoxim.
Etrolizumab
go.drugbank.com/drugs/DB12189InvestigationalInflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is typified by a chronic gastrointestinal inflammatory microenvironment, driven in part by the excessive infiltration
Rexin G
go.drugbank.com/drugs/DB16450InvestigationalIt is under development by Epeius Biotechnologies for the potential treatment of metastatic cancer. It is also being investigated for preventing SARSCOV-2 viral entry.
Thiothixene
go.drugbank.com/drugs/DB01623ApprovedA thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.
Virginiamycin M1
go.drugbank.com/drugs/DB01669ExperimentalIt is produced by Streptomyces graminofaciens and other bacteria.
Bupranolol
go.drugbank.com/drugs/DB08808ExperimentalIt does not have intrinsic sympathomimetic activity (ISA), but does have strong membrane stabilizing activity.
Talopram
go.drugbank.com/drugs/DB09190ExperimentalIt was researched in the 1960s and 1970s but never marketed.
Demegestone
go.drugbank.com/drugs/DB13857ExperimentalIt was previously marketed in France as Lutionex, but has since been discontinued.